Altered brain-gut axis in autism: Comorbidity or causative mechanisms?

BioEssays

Volumn 36, Issue 10, 2014, Pages 933-939

  Mayer, Emeran A ^a   Padua, David ^a   Tillisch, Kirsten ^a  

^a UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

Brain gut interactions; Gut microbiome; Intestinal permeability; Neurodevelopment disorder

Indexed keywords

PROBIOTIC AGENT;

ARTICLE; AUTISM; COMORBIDITY; GASTROINTESTINAL SYMPTOM; HUMAN; INFECTION; INTESTINE FLORA; INTESTINE INNERVATION; METABOLITE; MICROBIOME; NONHUMAN; PATHOPHYSIOLOGY; PREVALENCE; SIGNAL TRANSDUCTION; ANIMAL; AUTISTIC DISORDER; BRAIN; COMPLICATION; GASTROINTESTINAL DISEASE; GASTROINTESTINAL TRACT; MICROBIOLOGY; MICROFLORA; PATHOLOGY;

ANIMALS; AUTISTIC DISORDER; BRAIN; GASTROINTESTINAL DISEASES; GASTROINTESTINAL TRACT; HUMANS; MICROBIOTA; PROBIOTICS;

EID: 84908152766     PISSN: 02659247     EISSN: 15211878     Source Type: Journal    
DOI: 10.1002/bies.201400075     Document Type: Article

References (51)

1. Wakefield AJ, Murch SH, Anthony A, Linnell J, et al. 1998. Ileal-lymphoid-nodular hyperplasia, non-specific colitis, and pervasive developmental disorder in children. Lancet 351: 637-41.
2. Human Microbiome Project Consortium. 2012. Structure, function and diversity of the healthy human microbiome. Nature 486: 207-14.
3. Lyte M. 2014. Microbial endocrinology: host-microbiota neuroendocrine interactions influencing brain and behavior. Gut Microbes 5, in press, doi: 10.4161/gmic.28682.
4. Collins SM, Bercik P. 2009. The relationship between intestinal microbiota and the central nervous system in normal gastrointestinal function and disease. Gastroenterology 136: 2003-14.
5. Collins SM, Surette M, Bercik P. 2012. The interplay between the intestinal microbiota and the brain. Nat Rev Microbiol 10: 735-42.
6. Cryan JF, Dinan TG. 2012. Mind-altering microorganisms: the impact of the gut microbiota on brain and behaviour. Nat Rev Neurosci 13: 701-12.
7. Tillisch K, Labus J, Kilpatrick L, Jiang Z, et al. 2013. Consumption of fermented milk product with probiotic modulates brain activity. Gastroenterology 144: 1394-401.e4.
8. American Psychiatric Association. 2013. Diagnostic and Statistical Manual of Mental Disorders, Fifth Edition. Arlington, VA: American Psychiatric Association.
9. Lotter V. 1966. Epidemiology of autistic conditions in young children. Soc Psychiatry 1: 124-37.
10. lwainsky H. 1988. Mode of action, biotransformation and pharmacokinetics of antituberculosis drugs in animals and man, Antituberculosis Drugs. In Bartmann K, ed; Handbook of Experimental Pharmacology, Vol. 84, Heidelberg, Berlin: Springer. p. 399.
11. Won H, Mah W, Kim E. 2013. Autism spectrum disorder causes, mechanisms, and treatments: focus on neuronal synapses. Front Mol Neurosci 6: 19.
12. Muhle R, Trentacoste SV, Rapin I. 2004. The genetics of autism. Pediatrics 113: e472-86.
13. Coury DL, Ashwood P, Fasano A, Fuchs G, et al. 2012. Gastrointestinal conditions in children with autism spectrum disorder: developing a research agenda. Pediatrics 130: S160-8.
14. Mouridsen SE, Isager T, Rich B. 2013. Diseases of the gastrointestinal tract in individuals diagnosed as children with atypical autism: a Danish register study based on hospital diagnoses. Autism 17: 55-63.
15. Black C, Kaye JA, Jick H. 2002. Relation of childhood gastrointestinal disorders to autism: nested case-control study using data from the UK General Practice Research Database. BMJ 325: 419-21.
16. McElhanon BO, McCracken C, Karpen S, Sharp WG. 2014. Gastrointestinal symptoms in autism spectrum disorder: a meta-analysis. Pediatrics 133: 872-83.
17. Doshi-Velez F, Ge Y, Kohane I. 2014. Comorbidity clusters in autism spectrum disorders: an electronic health record time-series analysis. Pediatrics 133: e54-63.
18. Wang LW, Tancredi DJ, Thomas DW. 2011. The prevalence of gastrointestinal problems in children across the United States with autism spectrum disorders from families with multiple affected members. J Dev Behav Pediatr 32: 351-60.
19. Mazefsky CA, Schreiber DR, Olino TM, Minshew NJ. 2013. The association between emotional and behavioral problems and gastrointestinal symptoms among children with high-functioning autism. Autism 18: 493-501.
20. van Steensel FJA, Bögels SM, Perrin S. 2011. Anxiety disorders in children and adolescents with autistic spectrum disorders: a meta-analysis. Clin Child Fam Psychol Rev 14: 302-17.
21. Cermak SA, Curtin C, Bandini LG. 2010. Food selectivity and sensory sensitivity in children with autism spectrum disorders. J Am Diet Assoc 110: 238-46.
22. Green SA, Ben-Sasson A. 2010. Anxiety disorders and sensory over-responsivity in children with autism spectrum disorders: is there a causal relationship? J Autism Dev Disord 40: 1495-504.
23. Mayer EA, Collins SM. 2002. Evolving pathophysiologic models of functional gastrointestinal disorders. Gastroenterology 122: 2032-48.
24. Ellingson BM, Mayer E, Harris RJ, Ashe-McNally C, et al. 2013. Diffusion tensor imaging detects microstructural reorganization in the brain associated with chronic irritable bowel syndrome. Pain 154: 1528-41.
25. Green SA, Rudie JD, Colich NL, Wood JJ, et al. 2013. Overreactive brain responses to sensory stimuli in youth with autism spectrum disorders. J Am Acad Child Adolesc Psychiatry 52: 1158-72.
26. Keita AV, Soderholm JD. 2010. The intestinal barrier and its regulation by neuroimmune factors. Neurogastroenterol Motil 22: 718-33.
27. Argyropoulos A, Gilby KL, Hill-Yardin EL. 2013. Studying autism in rodent models: reconciling endophenotypes with comorbidities. Front Hum Neurosci 7: 417.
28. Veenstra-VanderWeele J, Muller CL, Iwamoto H, Sauer JE, et al. 2012. Autism gene variant causes hyperserotonemia, serotonin receptor hypersensitivity, social impairment and repetitive behavior. Proc Natl Acad Sci USA 109: 5469-74.
29. Tabuchi K, Blundell J, Etherton MR, Hammer RE, et al. 2007. A neuroligin-3 mutation implicated in autism increases inhibitory synaptic transmission in mice. Science 318: 71-6.
30. Wang Y, Kasper LH. 2014. The role of microbiome in central nervous system disorders. Brain Behav Immun 38C: 1-12.
31. de Theije CG, Wu J, Koelink PJ, Korte-Bouws GA, et al. 2014. Autistic-like behavioural and neurochemical changes in a mouse model of food allergy. Behav Brain Res 261: 265-74.
32. Parracho HM, Bingham MO, Gibson GR, McCartney AL. 2005. Differences between the gut microflora of children with autistic spectrum disorders and that of healthy children. J Med Microbiol 54: 987-91.
33. Song Y, Liu C, Finegold SM. 2004. Real-time PCR quantitation of clostridia in feces of autistic children. Appl Environ Microbiol 70: 6459-65.
34. Finegold SM, Dowd SE, Gontcharova V, Liu C, et al. 2010. Pyrosequencing study of fecal microflora of autistic and control children. Anaerobe 16: 444-53.
35. Williams BL, Hornig M, Buie T, Bauman ML, et al. 2011. Impaired carbohydrate digestion and transport and mucosal dysbiosis in the intestines of children with autism and gastrointestinal disturbances. PLoS One 6: e24585.
36. Shaw W. 2010. Increased urinary excretion of a 3-(3-hydroxyphenyl)-3-hydroxypropionic acid (HPHPA), an abnormal phenylalanine metabolite of Clostridia spp. in the gastrointestinal tract, in urine samples from patients with autism and schizophrenia. Nutr Neurosci 13: 135-43.
37. Yap IK, Angley M, Veselkov KA, Holmes E, et al. 2010. Urinary metabolic phenotyping differentiates children with autism from their unaffected siblings and age-matched controls. J Proteome Res 9: 2996-3004.
38. Mayer EA, Savidge T, Shulman RJ. 2014. Brain-gut microbiome interactions and functional bowel disorders. Gastroenterology 146: 1500-12.
39. Knivsberg AM, Reichelt KL, Hoien T, Nodland M. 2002. A randomised, controlled study of dietary intervention in autistic syndromes. Nutr Neurosci 5: 251-61.
40. Whiteley P, Haracopos D, Knivsberg AM, Reichelt KL, et al. 2010. The ScanBrit randomised, controlled, single-blind study of a gluten- and casein-free dietary intervention for children with autism spectrum disorders. Nutr Neurosci 13: 87-100.
41. Hsiao EY, McBride SW, Hsien S, Sharon G, et al. 2013. Microbiota modulate behavioral and physiological abnormalities associated with neurodevelopmental disorders. Cell 155: 1451-63.
42. Desbonnet L, Clarke G, Shanahan F, Dinan TG, et al. 2014. Microbiota is essential for social development in the mouse. Mol Psychiatry 19: 146-8.
43. de Theije CG, Koelink PJ, Korte-Bouws GA, Lopes da Silva S, et al. 2014. Intestinal inflammation in a murine model of autism spectrum disorders. Brain Behav Immun 37: 240-7.
44. Garay PA, Hsiao EY, Patterson PH, McAllister AK. 2013. Maternal immune activation causes age- and region-specific changes in brain cytokines in offspring throughout development. Brain Behav Immun 31: 54-68.
45. Finegold SM, Downes J, Summanen PH. 2012. Microbiology of regressive autism. Anaerobe 18: 260-2.
46. Persico AM, Napolioni V. 2013. Urinary p-cresol in autism spectrum disorder. Neurotoxicol Teratol 36: 82-90.
47. Gilbert JA, Krajmalnik-Brown R, Porazinska DL, Weiss SJ, et al. 2013. Toward effective probiotics for autism and other neurodevelopmental disorders. Cell 155: 1446-8.
48. Wang L, Christophersen CT, Sorich MJ, Gerber JP, et al. 2013. Increased abundance of Sutterella spp. and Ruminococcus torques in feces of children with autism spectrum disorder. Mol Autism 4: 42.
49. De Angelis M, Piccolo M, Vannini L, Siragusa S, et al. 2013. Fecal microbiota and metabolome of children with autism and pervasive developmental disorder not otherwise specified. PLoS One 8: e76993.
50. Kang DW, Park JG, Ilhan ZE, Wallstrom G, et al. 2013. Reduced incidence of Prevotella and other fermenters in intestinal microflora of autistic children. PLoS One 8: e68322.
51. Gondalia SV, Palombo EA, Knowles SR, Cox SB, et al. 2012. Molecular characterisation of gastrointestinal microbiota of children with autism (with and without gastrointestinal dysfunction) and their neurotypical siblings. Autism Res 5: 419-27.